{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:17:20Z","timestamp":1790140640834,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.yebeh.2023.109260","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T15:26:46Z","timestamp":1685028406000},"page":"109260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The effect of anti-seizure medications on lipid values in adults with epilepsy"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8180-4331","authenticated-orcid":false,"given":"Ashley L.","family":"Muller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Diaz-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4760-857X","authenticated-orcid":false,"given":"Mackenzie C.","family":"Cervenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5545-7612","authenticated-orcid":false,"given":"Tanya J.W.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yebeh.2023.109260_b0005","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.yebeh.2023.109260_b0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs a 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2023.109260_b0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eplepsyres.2016.08.027","article-title":"Influence of antiepileptic drugs on serum lipid levels in adult epilepsy patients","volume":"127","author":"Yamamoto","year":"2016","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109260_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Enzyme induction with antiepileptic drugs: Cause for concern?","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"issue":"13","key":"10.1016\/j.yebeh.2023.109260_b0025","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/jama.2022.3880","article-title":"Antiseizure Medications for Adults with Epilepsy: A Review","volume":"327","author":"Kanner","year":"2022","journal-title":"JAMA - J Am Med Assoc"},{"issue":"8","key":"10.1016\/j.yebeh.2023.109260_b0030","article-title":"Evaluation of effect of antiepileptic drugs on serum lipid profile among young adults with epilepsy in a tertiary care hospital in Pondicherry","volume":"8","author":"Manimekalai","year":"2014","journal-title":"J Clin Diagnostic Res"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109260_b0035","first-page":"50","article-title":"The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy","volume":"10","author":"Nikolaos","year":"2004","journal-title":"Med Sci Monit"},{"issue":"9","key":"10.1016\/j.yebeh.2023.109260_b0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.seizure.2014.05.011","article-title":"The effects of antiepileptic drugs on vascular risk factors: A narrative review","volume":"23","author":"Katsiki","year":"2014","journal-title":"Seizure"},{"issue":"SUPPL. 190","key":"10.1016\/j.yebeh.2023.109260_b0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0404.2010.01372.x","article-title":"Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine","volume":"122","author":"Svalheim","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2023.109260_b0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.eplepsyres.2015.03.002","article-title":"Antiepileptic drug use for treatment of epilepsy and dyslipidemia: Systematic review","volume":"113","author":"Vyas","year":"2015","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.yebeh.2023.109260_b0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","article-title":"Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular","volume":"21","author":"Stein","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"issue":"9","key":"10.1016\/j.yebeh.2023.109260_b0060","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.amjcard.2014.02.003","article-title":"Usefulness of coronary and carotid imaging rather than traditional atherosclerotic risk factors to identify firefighters at increased risk for cardiovascular disease","volume":"113","author":"Ratchford","year":"2014","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109260_b0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199901073400103","article-title":"Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults","volume":"340","author":"O\u2019Leary","year":"1999","journal-title":"N Engl J Med"},{"issue":"9831","key":"10.1016\/j.yebeh.2023.109260_b0070","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(12)60441-3","article-title":"Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data","volume":"379","author":"Lorenz","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109260_b0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1167.2011.03316.x","article-title":"Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis","volume":"53","author":"Chuang","year":"2012","journal-title":"Epilepsia"},{"issue":"2\u20133","key":"10.1016\/j.yebeh.2023.109260_b0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eplepsyres.2007.03.010","article-title":"Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy","volume":"74","author":"Hamed","year":"2007","journal-title":"Epilepsy Res"},{"issue":"7","key":"10.1016\/j.yebeh.2023.109260_b0085","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00415-002-0731-3","article-title":"Polycystic ovaries, obesity and insulin resistance in women with epilepsy: A comparative study of carbamazepine and valproic acid in 105 women","volume":"249","author":"Luef","year":"2002","journal-title":"J Neurol"},{"issue":"10","key":"10.1016\/j.yebeh.2023.109260_b0090","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1111\/epi.12338","article-title":"Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy","volume":"54","author":"Kim","year":"2013","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.yebeh.2023.109260_b0095","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/epi.14554","article-title":"Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly","volume":"59","author":"Mintzer","year":"2018","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.yebeh.2023.109260_b0100","article-title":"Ketogenic diets for drug-resistant epilepsy (Review)","volume":"11","author":"Martin-McGill","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109260_b0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1471-4159.2012.07670.x","article-title":"Ketone bodies in epilepsy","volume":"121","author":"McNally","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2023.109260_b0110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cnp.2017.06.001","article-title":"The role for ketogenic diets in epilepsy and status epilepticus in adults","volume":"2","author":"Williams","year":"2017","journal-title":"Clin Neurophysiol Pract"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109260_b0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/epi4.12098","article-title":"Ketogenic diet for treatment of intractable epilepsy in adults: A meta-analysis of observational studies","volume":"3","author":"Liu","year":"2018","journal-title":"Epilepsia Open"},{"issue":"2","key":"10.1016\/j.yebeh.2023.109260_b0120","first-page":"72","article-title":"Modified atkins diet in adult patients with refractory epilepsy: A controlled randomized clinical trial","volume":"16","author":"Zare","year":"2017","journal-title":"Iran J Neurol"},{"key":"10.1016\/j.yebeh.2023.109260_b0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.seizure.2018.06.019","article-title":"Improving compliance in adults with epilepsy on a modified Atkins diet : A randomized trial","volume":"60","author":"Mcdonald","year":"2018","journal-title":"Seizure Eur J Epilepsy"},{"issue":"8","key":"10.1016\/j.yebeh.2023.109260_b0130","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/epi.14457","article-title":"Effect of modified Atkins diet in adults with drug-resistant focal epilepsy: A randomized clinical trial","volume":"59","author":"Kverneland","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109260_b0135","first-page":"1","article-title":"Six-month effects of modified Atkins diet implementation on indices of cardiovascular disease risk in adults with epilepsy","author":"Mcdonald","year":"2021","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.yebeh.2023.109260_b0140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.yebeh.2017.10.035","article-title":"Impact of the modified Atkins diet on cardiovascular health in adults with epilepsy","volume":"79","author":"McDonald","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.yebeh.2023.109260_b0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/CPJ.0000000000001007","article-title":"International Recommendations for the Management of Adults Treated With Ketogenic Diet Therapies","volume":"11","author":"Cervenka","year":"2021","journal-title":"Neurol Clin Pract"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109260_b0150","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"issue":"19","key":"10.1016\/j.yebeh.2023.109260_b0155","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.yebeh.2023.109260_b0160","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","author":"Cleeman","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.yebeh.2023.109260_b0165","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"25 SUPPL. 1","key":"10.1016\/j.yebeh.2023.109260_b0170","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: A report of the American college of cardiology\/American heart association task force on practice guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.yebeh.2023.109260_b0175","series-title":"Dietary DRI Reference Intakes","author":"Otten","year":"2006"},{"key":"10.1016\/j.yebeh.2023.109260_b0180","article-title":"Therapeutic Monitoring of Antiepileptic","volume":"Vol 7","author":"Landmark","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.yebeh.2023.109260_b0185","series-title":"Atlas of Epilepsies","article-title":"Atlas of Epilepsies","author":"Patsalos","year":"2010"},{"issue":"7","key":"10.1016\/j.yebeh.2023.109260_b0190","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1528-1167.2008.01665.x","article-title":"Rufinamide: Clinical pharmacokinetics and concentration-response relationships in patients with epilepsy","volume":"49","author":"Perucca","year":"2008","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109260_b0195","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/j.1875-9114.2012.01028.x","article-title":"Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes","volume":"32","author":"Walzer","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.yebeh.2023.109260_b0200","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1111\/epi.16745","article-title":"Effects of lacosamide and carbamazepine on lipids in a randomized trial","volume":"61","author":"Mintzer","year":"2020","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109260_b0205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/FTD.0b013e31827ada88","article-title":"Clobazam therapeutic drug monitoring: A comprehensive review of the literature with proposals to improve future studies","volume":"35","author":"De Leon","year":"2013","journal-title":"Ther Drug Monit"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023001798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023001798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:50:49Z","timestamp":1761504649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505023001798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":41,"alternative-id":["S1525505023001798"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109260","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of anti-seizure medications on lipid values in adults with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109260"}}